This slideshow reviews brentuximab vedotin (Adcetris), indicated for treatment of Hodgkin lymphoma (HL) after failure of autologous stem cell transplant ...
This slideshow reviews cabazitaxel (Jevtana), indicated, in combination with prednisone, for the treatment of hormone refractory metastatic prostate cancer in ...
This slideshow reviews Tbo-figrastim (Granix), indicated for reduction in the duration of severe neutropenia in patients with non-myeloid malignancies receiving ...
This slideshow reviews vemurafenib (Zelboraf), indicated for the treatment of unresectable or metastatic melanoma with BRAF V600E mutation.
This slideshow reviews ofatumumab (Arzerra), indicated for the treatment of patients with chronic lymphocytic leukemia (CLL) refractory to fludarabine and ...
This slideshow reviews vincristine, indicated for Hodgkin disease, Kaposi sarcoma, leukemia, neuroblastoma, non-Hodgkin lymphoma, rhabdomyosarcoma, and Wilms' tumor.
This slideshow reviews paclitaxel protein-bound particles (Abraxane), indicated for metastatic breast cancer, locally advanced or metastatic non-small cell lung cancer, ...
This slideshow reviews pazopanib, indicated for the treatment of advanced renal cell carcinoma and advanced soft tissue sarcoma.
This slideshow reviews azacitidine (Vidaza), Indicated for the treatment of French-American-British (FAB) myelodysplastic syndrome subtypes.
This slideshow examines bendamustine (Treanda), indicated for the treatment of chronic lymphocytic leukemia (CLL) and indolent B-cell non-Hodgkin lymphoma (NHL).
This slideshow reviews afatinib (Gilotrif) for the treatment of non-small cell lung cancer (NSCLC).
This slideshow reviews Pertuxumab (Perjeta) for the treatment of HER2-positive metastatic breast cancer in combination with trastuzumab (Herceptin) and docetaxel ...
This slideshow reviews Tamoxifen for the treatment of metastatic breast cancer in women and men
This slideshow reviews Glucarpidase (Voraxaze) for the treatment of toxic plasma methotrexate concentrations (>1 μmol/L) in patients with delayed methotrexate ...
This slideshow reviews Axitinib (Inlyta) for the treatment of advanced renal cell carcinoma (RCC) after failure of prior systemic therapy.
This slideshow reviews Vismodegib (Erivedge) for the treatment of metastatic basal cell carcinoma.
Asparaginase Erwinia chrysanthemi is a component of a multiagent regimen for treatment of acute lymphoblastic leukemia.
An antibody-drug conjugate indicated for the treatment of Hodgkin lymphoma and sALCL after failure of prior multiagent regimens.
Methylnaltrexone is a peripheral acting narcotic antagonist, opioid reversing agent. It is indicated for treatment of opioid-induced constipation.
Ipilimumab is a recombinant, human cytotoxic T-lymphocyte antigen 4-blocking monoclonal antibody indicated for the treatment of unresectable or metastatic melanoma.
Oxaliplatin is a platinum-containing antineoplastic agent used to treat lymph node positive colorectal carcinoma and metastatic colorectal cancer.
Fluorouracil is an antimetabolite antineoplastic agent indicated for colorectal, gastric, metastatic breast, metastatic colorectal, and pancreatic cancers.
Cisplatin is a platinum-containing, aklylating agent. It is often used in combination with other chemotherapy agents as well as monotherapy because of its relative lack of hematologic toxicity.
Erlotinib is a human epidermal growth factor receptor type 1/epidermal growth factor receptor (HER1/EGFR) tyrosine kinase inhibitor approved for non-small cell lung cancer and pancreatic cancer.
Zoledronic acid is a third-generation bisphosphonate prescribed to reduce pain from bony metastases, treat hypercalcemia of malignancy, and manage osteolytic lesions in multiple myeloma.
Doxorubicin is an anthracycline antibiotic that is used to treat lymphoblastic and acute myeloblastic leukemias, several types of cancer, Kaposi sarcoma related to AIDS, malignant lymphoma, soft tissue and osteogenic sarcomas, and Wilms tumor.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|